ABSTRACT: Pure cultures of Edwarsiella tarda were isolated from body ulcers and internal organs of wild European eels caught in a Mediterranean freshwater coastal lagoon (Albufera Lake, Valencia, Spain) over a 1 yr period. Overall, the E. tarda isolation rate from wild eels was 9%, but this increased to 22.8% in diseased individuals. All 22 E. tarda isolates belonged to the 'wild-type' biogroup of the species and were virulent for eels (lethal dose that kills 50% of exposed individuals [LD 50 dose]: 10 4.85 to 10 6.83 CFU ind.
INTRODUCTION
Edwardsiella tarda is the causative agent of edwardsiellosis, a common epizootic disease of cultured (Meyer & Bullock 1973 , Wakabayashi & Egusa 1973 , Kusuda & Kawai 1998 and wild fish species (FrancisFloyd et al. 1993 , Baya et al. 1997 . It has been reported in tropical and subtropical areas of Africa, America, Asia and Australia. Moreover, E. tarda is recognized as a serious human pathogen that may cause gastrointestinal and extraintestinal infections (Janda & Abbott 1993) . Risk factors associated with E. tarda infections in humans include exposure to aquatic environments or exotic animals, pre-existing hepatobiliary diseases, and eating habits (Vandepitte et al. 1983 , Mowbray et al. 2003 , Wang et al. 2005 .
To date, Edwardsiella tarda isolations in Europe have been rare, the only reports being those related to its recovery from ornamental tropical fish and cultured turbot (Vladik et al. 1983 , Nougayrede et al. 1994 . In Europe, E. tarda has not been associated with bacterial infections affecting the European eel Anguilla anguilla (Biosca et al. 1991 , Esteve et al. 1993 , Høi et al. 1998 , even though intensive eel farming is widely practised to satisfy market demands and supplement declining wild eel stocks. The occurrence of edwardsiellosis in eel has so far been limited to the Japanese and Taiwanese aquaculture industry (Wakabayashi & Egusa 1973 , Chang & Liu 2002 . In fact, the first isolation of the bacterium was in Japan, where Hoshina (1962) named the organism Paracolobactrum anguillimortiferum. The name E. tarda, which is now accepted world-wide, was proposed by Ewing et al. (1965) . Based on phenotypic characteristics, E. tarda isolates were grouped into 3 different biogroups (Ewing et al. 1965 , Grimont et al. 1980 , Walton et al. 1993 The present study is the first to describe the occurrence of Edwardsiella tarda 'wild-type' strains in wild European eels. Infected eels were caught in a Mediterranean freshwater coastal lagoon (Albufera Lake, Valencia, Spain). We tested our isolates for their virulence for eels and for their microbial susceptibilities. In addition, their serological relationships were studied and compared with the E. tarda type strain.
MATERIALS AND METHODS

Sample collection and microbiological analysis.
Over the period of 1 yr (October 2003 to December 2004 , the wild European eel Anguilla anguilla collected from Albufera Lake (Valencia, Spain) was studied on 10 occasions. Samples were mainly collected in autumn and winter, because eel (silver and yellow states) capture rates were highest during these seasons. Albufera Lake is a freshwater lagoon located 12 km south of Valencia city, close to the Mediterranean Sea, from which it is separated by a small littoral bar approximately 1 km wide. The lake is used for fishing and recreation; furthermore, lake water is used for agricultural purposes (rice cultivation). Eels are caught in the lagoon using traditional fishing procedures and are then briefly stocked in concrete ponds (160 × 80 cm) supplied with well freshwater (22 to 24°C) until sold. Edwardsiella tarda was not isolated from the well freshwater that supplied holding tanks, and the containers had only been used to hold European eels (data not shown).
A total of 88 eels were randomly chosen and analysed, including healthy eels as well as individuals showing pathological signs such as haemorrhagic fins, petechiae on the belly, and skin damage. Samples of skin, kidney and liver from both healthy and diseased animals were streaked onto tryptone soy agar plates (Oxoid) plus 1% (wt/vol) NaCl (TSA-1). All plates were incubated at 28°C for 24 to 48 h. Colonies of each morphological type were picked and transferred to TSA-1 plates for purification. Bacterial isolates were routinely subjected to conventional tests as previously described (Esteve et al. 1993) . API 20E strips (BioMérieux) were used to identify oxidative and fermentative bacteria (Edwardsiella spp. strains among the latter).
Phenotypic and serological characterization of Edwardsiella tarda isolates. E. tarda isolates recovered from wild European eels were further characterized using conventional plate and tube tests, which are currently used for E. tarda biotyping (Walton et al. 1993) . Susceptibility of E. tarda isolates to antimicrobials currently used in chemotherapy and veterinary treatments was tested on Mueller-Hinton agar (Pronadisa) as previously described (Bauer et al. 1966) . Type strain E. tarda CECT 849 T , which is a typical 'wild-type' strain of clinical origin (Ewing et al. 1965) , was used in the phenotypic characterization for comparative purposes.
To examine the serological relationships among Edwardsiella tarda isolates recovered from different sampling occasions, we chose the isolate S16-10 to produce polyclonal antiserum in white female New Zealand rabbits. S16-10 was recovered from the only wild European eel suffering from edwardsiellosis, which was analyzed in Survey 1. The antigen was formalin-killed cells, and the antiserum was generated by intravenous injection, as described previously (Sendra et al. 1997) . Slide agglutination tests were conducted with this polyclonal antiserum on all E. tarda isolates as well as on strain E. tarda CECT 849
T isolated from human faeces. Antiserum specificity was assessed using a strain of Escherichia coli CECT 515 as well as 5 Aeromonas hydrophila and Vibrio vulnificus isolates previously recovered from European eels as negative controls.
Virulence trials. Virulence of Edwardsiella tarda isolates was tested in juvenile European eels (elvers) by intraperitoneal (i.p.) injection. The fish (mean weight 6.2 g) were housed in 20 l aquariums supplied with freshwater and maintained at approximately 20°C. Briefly, fish were anesthetized by immersion in a freshwater bath plus benzocaine at 2% (wt/vol) (Ross & Ross 1984) , and then 6 ind. per dose were injected with 0.1 ml bacterial suspension containing 10 7 to 10 3 CFU ml -1 in phosphate buffered saline (PBS). Sterile PBS was injected i.p. into fish serving as controls. Mortalities were recorded daily for 7 d, and were only considered if pure cultures of injected E. tarda were recovered from dead fish. The LD 50 was calculated according to Reed & Müench (1938) . The virulence of strain E. tarda CECT 849 T was also assayed for comparative purposes.
RESULTS
Phenotypic and serological properties of Edwardsiella tarda isolates
Twenty-two Edwardsiella tarda isolates were obtained as pure cultures from necropsies of 8 wild European eels that showed haemorrhage at the base of the fins, petechial haemorrhage on the belly, enhanced mucus production and, in some cases, an ulcer in the opercula region. These 22 isolates showed API 20E codes that presumptively identified them as E. tarda (4 744 000, 4 344 000 and 4 144 000). Isolates were biochemically characterized using conventional plate and tube tests (Table 1) . Edwardsiella tarda isolates from wild eels showed biochemical homogeneity with each other and with type strain CECT 849 T , except under the conditions of Christensen's acetate test (Table 1) . All E. tarda isolates as well as E. tarda CECT 894 T produced H 2 S, but were non-reactive for acid production from L-arabinose, mannitol and sucrose, and so belonged to the 'wild-type' biogroup of this species (Table 1) .
The sensitivity of Edwardsiella tarda isolates to various antimicrobials was compared with that of type strain CECT 849 T (Table 2 ). Like the type strain, all E. tarda isolates were sensitive to ampicillin-sulbactam, cefotaxime, chloramphenicol, flumequine, nitrofurantoin, and oxolinic acid, but were resistant to vancomycin. Unlike the type strain, all but one of the isolates were resistant to clindamycin. Other differences between the isolates and type strain were minor. Among all E. tarda isolates, only isolate S23-12 was resistant to oxytetracycline and furazolidone.
All Edwardsiella tarda strains isolated from wild eels, as well as type strain E. tarda CECT 849 T , were strongly agglutinated by the rabbit polyclonal antiserum raised against formalin-killed cells of isolate S16-10. This agglutination reaction was similar regardless of the antigen (fresh whole cells or O antigen) used in tests (data not shown). No antigen derived from the Escherichia coli, Aeromonas hydrophila, or Vibrio vulnificus strains (the negative controls) was agglutinated by the anti-E. tarda S16-10 serum (data not shown).
Occurrence of edwardsiellosis in wild European eels
A total of 88 individuals were analysed from 10 collections of wild European eel Anguilla anguilla from Albufera Lake during autumn and winter of 2003 and 2004. Among them, 35 individuals (39.8%) were diseased fish, identified as such because they exhibited external pathological signs and yielded bacterial cultures from their internal organs. Specifically, wild European eels suffering from edwardsiellosis represented 9% (8 fish) of total individuals and 22.8% of total diseased fish (Table 3) . Strains of Aeromonas spp., Vibrio vulnificus, and Pseudomonas sp. were recovered from other diseased fish (data not shown). Incidence of edwardsiellosis in this wild eel population was confirmed throughout the sampling period. The mortality rate owing to edwardsiellosis among captive eels was of 0%, because all E. tarda-positive individuals recorded were alive. The morbidity rates observed were variable (from 0 to 28.6%), with the maximum recorded in October 2003 (Table 3) . These overall results suggest that holding conditions did not contribute to disease propagation in the captive eel population.
Eel pathogenicity of Edwardsiella tarda strains
The LD 50 at Day 7 of the Edwardsiella tarda strains used in virulence trials are shown in Table 3 . E. tarda isolates were virulent for eels, revealed by their LD 50 values, which ranged from 7.4 × 10 4 to 6.6 × 10 6 CFU ind. 
DISCUSSION
In the present study, we reported for the first time the presence of Edwardsiella tarda in wild European eels in Europe. Until now, E. tarda has never been associated with epizootics affecting wild or farmed eels in Europe (Biosca et al. 1991 , Esteve et al. 1993 , Høi et al. 1998 ). The infectivity experiments reported here clearly demonstrated that E. tarda was responsible for the disease signs occurring in some wild European eels from Albufera Lake (Valencia, Spain). The type strain of the species, which was isolated from human faeces, was not virulent for the European eel. It should be kept in mind that E. tarda CECT 849 T was originally described by Ewing et al. (1965) and has been subcultured since then in order to produce freeze-dried cultures by culture collection of microorganisms; therefore, its virulence could be attenuated.
Wild eel Edwardsiella tarda isolates and E. tarda CECT 894
T were biochemically and serologically related: both belonged to the 'wild-type' biogroup of the species (Ewing et al. 1965 , Grimont et al. 1980 , Walton et al. 1993 ) and were strongly agglutinated by the polyclonal antiserum raised against E. tarda S16-10. No antigenic cross-reactivity was observed between E. tarda and antigens derived from isolates of Aeromonas hydrophila and Vibrio vulnificus. This contrasts with results reported by other authors (Sendra et al. 1997 , Swain et al. 2003 ) who described antigenic sharing between A. hydrophila and E. tarda. Most E. tarda isolates showed resistance patterns to antimicrobials similar to that displayed by the E. tarda type strain, all of them being in accordance with the usual antibiotic susceptibilities described for Edwardsiella species (Stock & Wiedemann 2001) . Thus, our E. tarda isolates were resistant to macrolides, lincosamides, and glycopeptides, as well as to antifolates that currently inhibit E. tarda growth (Stock & Wiedemann 2001) . In addition, the isolate E. tarda S23-11 was resistant to oxytetracycline and furazolidone, and so could be a candidate for the search for the presence of R plasmids (Toranzo et al. 1983 , Aoki & Takahashi 1987 . Edwardsiella tarda is recognized as a pathogen of cultured eels, as well as a natural inhabitant of fish, reptiles, and other cold-blooded animals, which occurs throughout the world with the exception of Europe. It is considered endemic to tropical countries, where high recovery rates of aquatic animals are common and where it also causes infections in humans and cultured fish (White et al. 1973 , Kourany et al. 1977 , Van Damme & Vandepitte 1980 , Francis-Floyd et al. 1993 , Baya et al. 1997 , Chang & Liu 2002 , Swain et al. 2003 . In our study, the rates at which E. tarda was isolated from wild European eels were similar to those reported for freshwater fish in the tropics, which were in the range of 8 to 57% (Van Damme & Vandepitte 1980 , Faye et al. 1988 . Because the presence of E. tarda in the wild European eel population of Albufera Lake was demonstrated for over a year, it was concluded that it may be present in the wetlands of Mediterranean Europe. Its presence in such locations poses potential hazards for the aquaculture industry.
